Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8994345 | Journal of Pharmaceutical Sciences | 2005 | 12 Pages |
Abstract
Inclusion complexation between celecoxib, a specific cyclooxygenase II inhibitor, and betaâcyclodextrin (βâCD) was studied in solution and solid state. Drug cyclodextrin complexes were prepared by spray drying while physical mixtures were obtained by simple blending. Inclusion complexes were characterized by nuclear magnetic resonance spectroscopy (NMR), differential scanning calorimetry (DSC), Xâray diffractometry (XRD), scanning electron microscopy (SEM), infrared spectroscopy (IR), and polarimetry. Phase solubility analysis was carried out to determine the stability constant. Solubility studies revealed the existence of a 1:1 complex between celecoxib and βâCD. NMR studies suggested a strong interaction between celecoxib and βâCD prepared by spray drying. XRD and SEM analysis illustrated that celecoxib existed as an amorphous complexed form in sprayâdried complexes. Dissolution studies showed that the celecoxib entrapped in sprayâdried complexes dissolved much faster than the uncomplexed drug and physical mixtures. The data obtained suggest that celecoxib forms an inclusion complex with βâCD in solution and solid state, which was confirmed by various analytical techniques. A shorter t50% of dissolution is found for the formulation prepared by spray drying when compared on a weight basis in a USP II apparatus. © 2005 WileyâLiss, Inc. and the American Pharmacists Association J Pharm Sci 94:676-687, 2005
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
V.R. Sinha, R. Anitha, S. Ghosh, A. Nanda, R. Kumria,